Trastuzumab: a review of its use in HER2-positive advanced gastric cancer.
about
Microarray analysis in gastric cancer: a review.BMI and lymph node ratio may predict clinical outcomes of gastric cancer.Protein Profiling Gastric Cancer and Neighboring Control Tissues Using High-Content Antibody Microarrays.Epidermal growth factor receptor (EGFR), HER2 and insulin-like growth factor-1 receptor (IGF-1R) status in ovarian adult granulosa cell tumours.Next generation sequencing-based emerging trends in molecular biology of gastric cancer.
P2860
Trastuzumab: a review of its use in HER2-positive advanced gastric cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Trastuzumab: a review of its use in HER2-positive advanced gastric cancer.
@en
type
label
Trastuzumab: a review of its use in HER2-positive advanced gastric cancer.
@en
prefLabel
Trastuzumab: a review of its use in HER2-positive advanced gastric cancer.
@en
P2860
P1433
P1476
Trastuzumab: a review of its use in HER2-positive advanced gastric cancer.
@en
P2093
Mark Sanford
P2860
P2888
P304
P356
10.1007/S40265-013-0119-Y
P577
2013-09-01T00:00:00Z
P6179
1008434132